Abstract
RESULTS
Like the previous mortality fluctuations that have occurred in Russia since the mid1980s, the increase in life expectancy was driven by deaths at ages 15 to 60 from alcohol-related causes. Uniquely in the recent period, there were also improvements at older ages, especially in cerebrovascular disease mortality among women. In addition, there were reductions in deaths from avoidable causes, such as from tuberculosis and diabetes. The life expectancy gap between Russia and Western countries remains large, and is mostly attributable to deaths from cardiovascular disease, alcohol-related conditions, and violence.
CONCLUSIONS
The decrease in alcohol-related mortality may be attributable to measures taken in 2006 to control the production and sale of ethanol. The lower number of cerebrovascularrelated deaths may reflect advancements in blood pressure control. The reduction in the number of deaths from tuberculosis and diabetes may be associated with a general improvement in health care. Although the decline in mortality since 2004 has been substantial, the question of whether it can be sustained remains open.
Background
Worldwide, life expectancy has increased steadily over the past six decades, with two main exceptions: the countries of sub-Saharan Africa severely afflicted by the AIDS epidemic, and the countries of the former Soviet Union (McMichael et al. 2004 ). However, in this latter group, it appears that there may be some grounds for optimism. Since 2004, Russia, along with most other former Soviet republics, has experienced clear and relatively steep increases in life expectancy. This is the longest period of improvement seen in Russia since the mid-1960s. What is unclear, however, is whether these trends are simply the latest phase in a continuing cycle of increases and decreases that have characterized mortality in Russia over the past three decades, or whether there are new features that mark a break from the past. In the mid-1980s, following two decades of stagnation, life expectancy in Russia improved rapidly. This coincided with the implementation of a wide-ranging campaign against alcohol by the new General Secretary of the Communist Party of the USSR, Mikhail Gorbachev. Unfortunately, this campaign was short-lived. As both the antialcohol campaign and the wider policy of perestroika faltered, the earlier increase in life expectancy went into reverse. After the USSR broke apart in 1991, life expectancy fell sharply as the successor states were plunged into severe economic crises (Leon et al. 1997 ). The lowest point was reached in 1994, after which there was an equally rapid Paris, France) and the Centre for Demography and Human Ecology, Moscow, Russia . Compared to the data in the WHO Mortality Database, these data include more detailed causes of death, cover a longer time period, and are adjusted for distortions induced by changes in the classification of causes of death.
For the period 1994 to 2010, similar data were extracted from the original files compiled by Rosstat, the Russian State Statistical Agency. It should be noted that, historically, the Russian statistical system used aggregated diagnostic categories rather than the more detailed International Classification of Diseases (ICD) issued by the World Health Organization. However, in the reconstructed data set, the 175 categories have been mapped onto broad categories within ICD-9. The data series was continued up to 1998. For the period 1999-2010, the data include about 270 causes based on detailed ICD-10 codes. In this paper, we aggregate these categories into broad groupings that are consistent across the time period.
We place the changes in Russia since 1965 within a broader context by comparing them with developments in selected comparator countries, from Eastern Europe (the Czech Republic, Estonia, and Ukraine) and from Western Europe (the UK), with these data extracted from the Human Mortality Database (Human Mortality Database 2012).
We then examined in more detail the change in overall life expectancy in Russia between 2003 and 2010, identifying the contribution of deaths from major causes, and in different age groups using the decomposition method developed by Andreev and colleagues (Andreev 1982; Andreev, Shkolnikov, and Begun 2002) . A more detailed analysis of temporal changes in Russia and of the differences between Russia and the UK was undertaken using cause-specific age-standardized death rates. These were (directly) age-standardized using the European Standard Population (Benjamin and Pollard 1980 ; World Health Organisation Regional Office for Europe, 2012).
Results

Life expectancy at birth in Russia and comparator countries
Since 1965, Russian trends in life expectancy at birth contrast markedly with those in the UK (Figure 1 ). While there has been a steady increase in the UK, the overall pattern for most of the period is one of decline for Russian males and stagnation for females. Despite recent improvements, it is particularly striking that life expectancy for men in 2010 was, at 63 years, still below the level achieved in 1965. However, as a result of recent gains, life expectancy for women in 2010 reached 74.8 years; the highest level ever achieved in Russia. These diverging trends have resulted in a widening of the life expectancy gap between Russia and the UK from three years for men and 1.5 years for women in 1965, to 15 and seven years, respectively, in 2010.
The other extraordinary feature of the Russian trends shown in Figure 1 is the sharp fluctuation in life expectancy, which became particularly pronounced after 1984, when a series of steep increases and decreases occurred. These can be broken down into a number of phases: an increase in 1985-1987 (during the anti-alcohol campaign), a slow decrease in 1986-1991 (during the weakening of the campaign), a dramatic drop in 1992-1994 (following the collapse of the Soviet Union), an increase in 1995-1998 (a period of adaptation), a decrease in 1999-2003 (following the financial crisis in Russia in August 1998), and, finally, an increase since 2004. This most recent upward trend is of longer duration than any of the other preceding increases or decreases. The rate of improvement varied somewhat across the period. It was low in 2004-5, but greatly accelerated in 2006. A slowdown at the end can be attributed to the summer heat wave in 2010 (Revich and Shaposhnikov 2012) . 1965 1970 1975 1980 1985 1990 1995 2000 2005 2010 Czech Republic Estonia Russia Ukraine United Kingdom   Women   55   60   65   70   75   80   85 1965 1970 1975 1980 1985 1990 1995 2000 2005 2010 Czech Republic Estonia Russia Ukraine United Kingdom
The trends in Ukraine have broadly paralleled those in Russia. Although Estonia initially underwent the same sharp fluctuations in life expectancy, from 1998 onward its trajectory diverged from that of Russia, as the Baltic state experienced steep and consistent increases. Life expectancy in the Czech Republic, which had stagnated in the 1970s and 1980s (Chenet et al. 1996) , started to increase almost as soon as communism in Czechoslovakia collapsed in 1989. Figure 2 shows proportional changes in all-cause mortality at different ages in Russia since 1980. Although the amplitude of variation in each age group is larger for men than women, the pattern is very similar. During the period 1970 to 2003, the wellknown contrast between improvement among children and deterioration or stagnation among adults is apparent. This has long been characteristic of the trends in mortality in Russia (Leon et al. 1997; Shkolnikov, Meslé, and Vallin 1996) . Mortality in infancy and childhood had decreased continuously, while mortality in every adult age group has gone up and down with the same tempo. In relative terms, however, these fluctuations have been the most pronounced at the working ages of 15 to 59.
Age patterns
Since 2000, mortality among children has been decreasing at a faster pace than in the preceding decades. Since 2005, mortality has also declined at every adult age among both men and women, although at ages 50 and above the decline was already underway from 2003. As a consequence, the age-standardized death rates in 2010 were lower than those in 2003 by about 40% at ages zero to 14, 25% at ages 15 to 59, 20% at ages 60 to 74, and 15% at ages 75 and older. However, despite this relatively long period of improvement, it was only at ages 75 and above for men and 65 and above for women that mortality in 2010 was lower than at any point in the past. At younger adult ages, mortality in 2010 remained higher than the levels seen in the mid-1980s, when the anti-alcohol campaign was in full swing.
Causes of death
The four panels in Figure 3 show mortality changes for selected causes of death for both sexes. Table A-1, which shows the ICD-10 codes for causes of death in Figure 3 ; and Figures A-4 and A-3, which present cause-specific trends for men and women, are in the appendix. The upper two panels of Figure 3 display trends in circulatory diseases and in external and alcohol-related causes. This latter group of causes underwent the largest relative changes. The lower left-hand panel shows mortality trends from various cancers. These are remarkable in that they appear to have had their own dynamic, which was largely independent of the fluctuations seen for most other causes. Most notably, there was no indication of a rise in rates following the collapse of the Soviet Union in the 1990s. The causes of death in the lower-right panel were selected because they are generally regarded as being especially sensitive to medical interventions; thus, fluctuations in the rates at which people die from these causes may reflect changes in the health care system (Nolte and McKee 2004) . This is an area in which the USSR increasingly lagged behind Western Europe from the 1960s onwards (Andreev et al. 2003) .
It is evident from Figure 3 that the trends for a number of causes of death have been steady, moving either up or down for two decades or more. These include all of the cancers shown. Because of the stability of these trends, none of them is useful in explaining why mortality as a whole declined from 2004 onwards. However, after around 2002-3, all of the other causes of death shown in Figure 3 had either stopped increasing, had plateaued, or had started to decrease. Most notably, mortality from tuberculosis, which had increased consistently since 1990, started to decline in 2006.
The steepest relative declines in the recent period were for external causes. This group of causes, which include those due to violence, is especially strongly associated with alcohol (Pridemore and Chamlin 2006) . For deaths from homicide and violence of unknown intent, poisoning by alcohol, and transport accidents, the decline started in 2004. Nevertheless, with the exception of suicide rates, overall mortality from each of these external causes remained higher in 2010 than in the mid-1980s. Given the importance of cerebrovascular disease as a cause of death, the recent declines in this cause are striking. By 2010, mortality rates for cerebrovascular disease had reached the lowest level ever achieved in Russia. However, ischemic heart disease mortality was higher in 2010 than it was in the mid-1980s. (Table A-2) . Over this period, male life expectancy at birth increased from 58.50 to 62.95 years, while female life expectancy increased from 71.83 to 74.79 years. Consistent with the trends noted above, reduced mortality at all age groups contributed to the improvements in life expectancy among both males and females. While lower mortality among children ages zero to 14 had a considerable impact on life expectancy, reduced mortality among adults had an even greater effect. Fewer deaths at working ages (45-64 years) had the most significant impact on increased life expectancy among men. Meanwhile, among women, lower mortality at ages 65 and above contributed the most to improvements in life expectancy, although the effect of fewer deaths at ages 45-64 was almost as large.
Age-and cause-specific contributions to the increase in life expectancy
Reductions in adult mortality from circulatory diseases and external causes were the main drivers of the increase in life expectancy. Neoplasms as a whole had a small positive effect. In the age group 15-44, lower external cause mortality made the biggest contribution to improved life expectancy. In this category, the decrease in the number of homicides had the greatest impact, although declines in mortality from alcohol poisoning, transport accidents, and suicide (in men) also had significant effects. At older ages, lower mortality from circulatory disease was the primary driver of increased life expectancy. In men and women ages 45-64, reductions in mortality from ischemic heart disease contributed most to the rise in life expectancy; while at ages 65 and above, reductions in mortality from cerebrovascular disease had the biggest impact. Indeed, the decline in cerebrovascular disease mortality was responsible for over half of the total improvement in life expectancy among women ages 65 and above, and for 40% of the increase among men in this age group. Note: $ A15-A19,B90,A00-A14,A20-B89,B91-B99,F10,J40-J47,P00-P96,Q00-Q99.
Russia compared with the UK
While substantial progress has been made in recent years, mortality in Russia remains very high compared to mortality in other European countries. With a combined life expectancy of 68.9 years, Russia ranked 49 th out of 50 countries in Europe in 2010, just ahead of Kazakhstan (World Health Organization Regional Office for Europe 2012). However, in order to understand Russian mortality in an international context, it is helpful to compare it with the mortality of a specific country, rather than of a regional grouping. The country we have chosen for this comparison is the UK. Relative to the rest of Europe, the UK ranks in the middle, with a life expectancy in 2009 of 78.1 years for males and 82.3 years for females.
Overall, the age-standardized total mortality among men is about 2.5 times greater in Russia than it is in the UK, and it is twice as high among women. In fact, at every age mortality in Russia is greater than in the UK, although the size of the gap varies substantially across the age spectrum: in infancy and childhood (0-14 years) mortality is twice as high, at ages 15-44 years it is four times higher, at ages 45-64 it is three times higher, and at ages 65+ years it is 1.4 times higher. Table 2 shows the mortality differences between Russia in 2010 and the UK in 2009 by cause and sex. In both absolute and relative terms, the biggest differences were in mortality from circulatory diseases and external causes for males and females, with one notable exception: mortality from tuberculosis. For this latter cause, rates in Russia were 40 times higher among males and 17 times higher among females. In the external cause category, there were very large differences in rates of homicide and alcohol poisoning. The gap in mortality from ischemic heart disease (IHD) was the largest for any cause in absolute terms, although in relative terms the differences for IHD and cerebrovascular disease were similar at between four and five times higher in Russia. Differences in cancer mortality varied by site, with particularly large relative gaps observed for stomach cancer. As can be seen in Table 2 , the only categories in which mortality was lower in Russia than in the UK were breast and lung cancers among women. This exceptional advantage was particularly pronounced for lung cancer. Note: $ A15-A19,B90,A00-A14,A20-B89,B91-B99,F10,J40-J47,P00-P96,Q00-Q99.
Discussion
This is the first study to examine systematically the increase in life expectancy in Russia that has occurred since 2004. The relatively long and continuous upward trend in life expectancy appears to have broken the pattern observed since the mid-1980s, in which relatively brief periods of improvement were followed by longer periods of deterioration. Recently published data show that life expectancy levels for both men and women have increased by a further 0.8-0.9 years in 2011, reaching 64 years for men and 75.6 years for women (Rosstat 2013) . Our analyses have shown that the recent improvements in life expectancy in Russia have mainly been driven by reductions in mortality from circulatory diseases and external causes. However, the marked improvements in these cause-of-death categories have been reinforced by positive trends in several other causes, most notably in tuberculosis, which increased between the collapse of the Soviet Union to the mid2000s.
Limitations
Before considering possible substantive explanations for these trends, we should note the limitations of our analyses. The main limitation is that the measurements and decompositions presented in this study relate to population-level effects, which cannot be used to establish causal relationships that apply at the level of individuals. These effects do, however, provide the necessary basis for formulating plausible hypotheses regarding the underlying causes of the improvements in life expectancy, and thus allow us to identify promising directions for future research based on more detailed data, which would enable us to better evaluate causal effects.
Beyond this general point, we should note that we used routinely collected mortality data in these analyses. The characteristics and quality of these data were studied in detail in the mid-1990s Shkolnikov, Meslé, and Vallin 1996) . These studies found that there was an under-registration of infant and old-age mortality in the 1950s and 1960s, which could have resulted in a slight overstatement of life expectancy in the years before the late 1960s. In addition, the Russian statistical system used a restricted definition of live birth during this period, which led to a 20% underestimate of the infant mortality rate (Andreev 1995; Kvasha and Kharkova 2011) . But since this definition has remained unchanged, the trends in infant deaths were not affected. Problems have also been associated with the registration and coding of causes of death in Russia. These issues have been most acute for the category of circulatory diseases, as some non-specific codes were frequently used when the precise cause of death was not known . More recently, a number of additional problems have arisen, such as an increase in the number of deaths at unknown ages and from unspecified causes Andreev et al. 2008; Gavrilova 2008) , and in the number of violent deaths of undetermined intent (Pridemore 2003) . For example, rates of homicide and suicide may have been affected by the misclassification of deaths from these two causes as unspecified violent deaths. While all of these problems are relatively minor and cannot affect the estimates of life expectancy and mortality rates by broad groups of causes (Leon et al. 1997; Wassermann and Varnik 1998; Andreev, Scherbov, Willekens 1995) , caution is advised when considering more specific and smaller cause-of-death categories, such as diabetes or liver cirrhosis, as there may have been some variation in registration practices.
Cause-specific trends and international differences
There are several important and unique features of recent trends which distinguish them from previous cyclical fluctuations. In 2010, female life expectancy reached an all-time high for Russia. This is attributable in large part to the marked decline in cerebrovascular disease mortality among women, particularly at older ages: among women ages 60 and above (and among men ages 75 and above), all-cause mortality reached a historically low level for Russia, even as the cerebrovascular disease mortality rate fell to its lowest point in four decades. This recent downward trend in cerebrovascular disease mortality brings the level in Russia closer to the levels observed in high-income European countries, where there have seen long-term declines in deaths from this cause (Feigin et al. 2009 ). Deaths from several other causes in 2010 had also decreased to the lowest levels seen in Russia since 1980, including suicide and stomach cancer. As the rate of stomach cancer had been declining for a very long time, most likely as a result of improvements in conditions during childhood (Leon 2001 ), this cause is not implicated in the cyclical fluctuations we have observed.
However, for many other causes of death, the 2010 rates were still highersometimes considerably higher-than the lowest points recorded for Russia. For a number of causes, the lowest point was reached at the height of Gorbachev's antialcohol campaign in the mid-1980s. These include deaths caused by acute alcohol poisoning, liver cirrhosis, tuberculosis, and ischemic heart disease. Deaths attributable to diabetes, an eminently avoidable disease, were also higher in 2010 than they were in 1980. Thus, life expectancy in Russia has the potential to increase further simply through a return to mortality levels for certain causes of death that had been achieved at some point in the past. If all of these causes of death (especially causes directly or indirectly related to alcohol) had been at the lowest levels ever recorded for Russia (in 1987, for most causes), life expectancy in 2010 would have been 69.7 years for men and 78.2 years for women (increases of 6.7 and 3.5 years, respectively). These figures suggest possible benchmarks that are realistically achievable in the short term. It is important to recognize, however, that, although this potential improvement is very substantial, it still would not close the current gap between Russia and the countries with the lowest mortality levels.
One striking observation from our analyses is that the causes of death which have fluctuated the most over time in Russia, and have tended to contribute most to the recent improvements in life expectancy, are generally the causes for which the biggest relative and sometimes absolute differences relative to the UK have been observed. At the other end of the spectrum, the death rates from cancer in Russia were found to have been immune to cyclical mortality fluctuations, to have contributed little to the overall improvement in life expectancy, and to have been more similar to the rates in the UK than for any other cause. Moreover, mortality was shown to have been lower in Russia than in the UK for some cancer sites (e.g., for female lung and breast cancers). However, circulatory disease mortality in Russia was found to have undergone moderate fluctuations over time, to have made a major contribution to recent improvements in life expectancy, and to have been much higher than in the UK. This strongly suggests that the best strategy for bringing life expectancy in Russia closer to European levels lies in tackling mortality from circulatory diseases and external causes.
Alcohol
The most dynamic element of mortality is driven by changeable contemporary conditions. Since the late 1980s, Russian mortality has undergone sharp fluctuations, especially at working ages. Many of these fluctuations have been related to the harmful effects of alcohol consumption Shkolnikov, Andreev, and Jdanov 2008) .
The mortality decrease in 2004-2010 was the longest decline since 1965. Apart from the short-term decreases in the 1980s and in the second half of the 1990s, there were two earlier decreases in mortality since 1970: in 1972-1973 and 1981-1982 . Both were relatively minor, and were associated with increases in vodka prices in the USSR (Takala 2002) . Thus, all of the mortality decreases between 1965 and 2003 were shortlived, and were associated with declines in alcohol consumption. A large fraction of the reduction in mortality between 2003 and 2010 is also attributable to lower alcohol use, including decreases in mortality from alcohol poisoning and other alcohol-related causes, accidents, violence, cardiovascular deaths, and hemorrhagic stroke at working ages. It is important to note that mortality dropped especially sharply after the introduction of new federal controls on ethanol production and sales in 2006 (Khalturina and Korotaev 2008; Levintova 2007) .
In the group of alcohol-related causes, there currently appears to be a disconnect between liver cirrhosis and other causes. Before 2004, mortality rates from liver cirrhosis and alcohol poisoning had always fluctuated in parallel. However, the substantial decline in acute alcohol poisoning in 2004-2010 was, unusually, accompanied by a persistently high rate of mortality from liver cirrhosis. While we cannot exclude some change in coding practices, this may indicate a reduction in the frequency of the kind of extreme drinking behavior associated with alcohol poisoning, even as the overall level of alcohol consumption remains high, which may be expected to result in chronic damage affecting not only the liver, but also the pancreas, heart, and other organs (Leon et al. 2010) .
So far, alcohol control policies in Russia have been characterized by episodic -campaigns,‖ each of which has had some short-term success. The most effective campaign was the one instituted by Gorbachev in 1985. But that initiative, like some earlier small-scale efforts, was based on short-lived, top-down strategies of coercion and control that failed to tackle the underlying causes of hazardous drinking or popular attitudes toward it. The measures implemented in 2006 were broader structural efforts that focused on controlling and limiting supply. Crucially, they required all companies that manufactured ethanol for any purpose to pay a large registration fee to do so. This led to the closure of many smaller companies unable to pay the fee. Those companies that were authorized were then covered by a new monitoring scheme: the United State Automated Information System (USIS). This system allowed for the computerized tracking of ethanol production on the premises where it was actually manufactured. Alongside these measures, industrial ethanol production became subject to excise tax, and a new list of denaturating substances was introduced that made a much larger proportion of non-beverage ethanol unpalatable to drink (Levintova 2007) . The introduction of USIS and the excise taxation on all ethanols were particularly important, as they made it much less likely that -hidden‖ ethanol would be diverted into the production of very cheap vodkas and non-beverage alcohols. This measure was of crucial importance given the compelling evidence that the consumption of ethanol from medical tinctures, eau-de-colognes, after-shaves, and industrial solvents has been a major factor in the high death rates at working ages in Russia ). The net effect of these measures was a reduction in the total production of ethanol in Russia for the first time since 1998.
Although the measures taken in 2006 are widely believed to have been effective in reducing mortality, there is more to be done. A survey of the availability of nonbeverage alcohols in 17 Russian cities in 2007 showed that these products were still available in many cities (Gil et al. 2009 ). This indicates the need for stronger enforcement. On the other hand, data from the Russian Longitudinal Monitoring Survey (RLMS) (Higher School of Economics 2012) suggest that there have been some favorable changes in drinking patterns that could mark the beginning of a sustained shift. A comparison of Round 9 (2000) and Round 17 (2008) of the RLMS shows that the share of beer in overall consumption of pure ethanol has increased, and the share of vodka has decreased. Among respondents aged 15 to 54, these shares in 2000 were 14.2% and 56.1% (n=2127), respectively; while the shares in 2008 were 31.6% and 50.9% (n=2593), respectively. The greatest change has taken place among the young. For example, among respondents aged 20 to 29, the share of beer in overall consumption increased from 23.2% (n=626) in 2000 to 51.8% (n=622) in 2008.
Smoking
In Russia, smoking rates have long been high among men, but have historically been very low among women . In contrast, the smoking epidemic in the UK was one of the earliest and most intense in Europe, with smoking among British women becoming common in the middle of the 20 th century. Yet smoking-related mortality among men in the UK has been falling for decades, and appears to have peaked for women. However, the situation in Russia is not as promising, as there is no indication that smoking rates have declined among men, and there is good evidence that they are increasing among women (Perlman et al. 2007 ). Because of the substantial lag effect between smoking and the onset of consequent disease, lung cancer rates among women in Russia are still very low compared to rates among women in the UK. However, this rare health advantage for Russian women, which is also reflected in low rates of smoking-induced circulatory disease, will be lost unless steps are taken to reverse the current upward trend in smoking among women. At the same time, lowering the smoking rates among Russian men is an urgent priority. A trend toward smoking cessation would result in substantial short-to medium-term health gains, given the growing evidence that risks of ischemic heart disease fall rapidly when people stop smoking, reaching levels in line with those of non-smokers within three to five years (Lightwood and Glantz 1997; Capewell and O'Flaherty 2011) .
Health system performance
Even as overall mortality was fluctuating between 1985 and 2003, death rates from cardiovascular death at ages 60 and above remained high and relatively stable compared to mortality at younger ages. However, between 2004 and 2010, both all-cause and circulatory disease mortality at older ages fell to historically low levels. It is notable that, in this recent period, both the absolute and relative declines were greater for cerebrovascular mortality than for mortality from ischemic heart disease. As with alcohol-related causes, this represented a break with the past, as the fluctuations in mortality from ischemic heart disease had always been much larger than the fluctuations in cerebrovascular mortality. This may be attributable to improved blood pressure control. The management of hypertension has long been poor in Russia, not only because it is under-diagnosed and undertreated, but also because there has been a failure to recognize the need for continuous treatment, rather than for only treating people when they are feeling unwell. Although longitudinal survey data on hypertension management in Russia are scarce, some data are available. Two surveys that posed the same questions in 2001 and 2010 found a slight decrease in the daily use of medication among respondents with a hypertension diagnosis (Roberts et al. 2010; .
Data collected in the framework of the Federal Target (Oganov et al. 2011) . Of perhaps greater importance, however, was the significant decrease in the prevalence of highly elevated blood pressure (SBP>170 mmHg or DBP>110 mmHg), from 19% to 10.1% among men and from 22.4% to 10.7% among women (Shalnova 2012) . Unfortunately, in the cited studies the sampling procedures and characteristics of the samples were not described in detail, and thus it is difficult to assess the validity of the findings.
The timing and characteristics of the positive changes in cardiovascular deaths suggest that improvements in the health care system had an impact. The PTAH program may have played a role in the improvement in hypertension control, as it included a package of measures to increase awareness of hypertension and to make the treatment of high blood pressure more effective. However, while the PTAH program may have affected cerebrovascular mortality in particular, it has not been subject to a formal evaluation, and thus there are no data on its coverage or effectiveness. Hence, it is not possible to quantify any positive effects on health the program might have had. The same is true for the other national health initiatives designed to prevent and treat -socially significant diseases‖ that were launched in 2007. These include programs aimed at diabetes, tuberculosis, HIV infection, cancer, sexually transmitted infections, viral hepatitis, mental disorders, and vaccine-preventable diseases. Of the corresponding causes of death, only the mortality downturn in tuberculosis, which began in 2006, approximately coincides with the implementation of the related health program.
The improvement in mortality from treatable cardiovascular causes seen at older ages is echoed in reductions in mortality from some other causes that contributed much less to the overall increase in life expectancy, but which might also be indicative of improvements in health care, and especially of the prevention of premature deaths from causes amenable to health care, such as tuberculosis and diabetes. While deaths from tuberculosis started to decrease in the mid-2000s, a reduction in deaths from diabetes began in the mid-1990s.
Mortality from a number of cancers has also declined. Most of these improvements started gradually in the 1990s. For the most common cancers, such as lung and stomach cancers, these changes were mainly determined by the incidence of these malignancies, and had little to do with medical practices Leon 2001; Zaridze et al. 2002; Zaridze 2012; Davidov and Axel 2011) . At the same time, mortality from some less common but more treatable cancers, such as leukemia, has decreased, despite an increase in the incidence of these cancers (Davidov and Axel 2011) ; again, this is consistent with improvements in medical care.
Although mortality among children under age 15 had been decreasing for decades, this trend accelerated after 2000. The increase has been especially steep for early neonatal mortality, and is therefore mainly attributable to the greater use of advanced technology in perinatal care (Kvasha and Kharkova 2011) .
Finally, it is important to note the role played by an ambitious, multi-purpose national priority project, known simply as -Health,‖ which began in 2006 (Popovich et al. 2011) . Through the project, the Russian health care system received direct subsidies from the federal budget. According to the WHO Office for Europe, Russia's health expenditure in PPP$US per capita increased 31% between 2005 and 2006 , and another 33% between 2006 (World Health Organization Regional Office for Europe 2012 . The project had four main priorities: the improvement of primary care, including higher salaries for general practitioners in polyclinics (since the beginning of 2006); the strengthening of the emergency care infrastructure; the promotion of high-technology medical care; and the construction by the federal government of new medical centers. Although the project's effects on health have not been objectively evaluated, it is possible that the increased investment has had a positive impact on health outcomes.
According to the Russia's Health Ministry, additional financing of modern medical technologies has resulted in a 2.5-fold rise in the number of high-technology medical services 5 provided, and in a 2.4-fold increase in the number of surgeries for ischemic heart disease performed (Minzdravsotsrazvitiya 2012). These interventions might have contributed to the reduction in mortality from ischemic heart disease, and from some other pathologies. However, despite these initiatives, the health service in Russia is still insufficient to respond adequately to the current health challenges, and many Russians in need of care are not yet receiving it . Thus, recent news that the Russian government intends to substantially reduce health care expenditures in the federal budgets for 2013-2015 is particularly worrying (Ministerstvo finansov Rossii 2012).
Conclusion
This study represents the first attempt to examine systematically the recent increases in Russian life expectancy. The improvements in the 2000s were mostly driven by decreases in mortality from cardiovascular diseases and external causes among adults. Our finding that the recent reduction in mortality at older ages from circulatory (and especially cerebrovascular) diseases has been greater than the earlier decreases in 1995-1998 and 1985-1987 is important. To some extent, this development is similar to changes that have taken place in the Czech Republic, Poland, and other Central European countries over the past two decades; as well as to shifts that occurred in the UK and other high-income countries in the 1970s (Meslé 2004; Rychtařiková 2004) . Does this mean that Russia is entering a new stage of health transition, known also as -cardiovascular revolution‖ )? It is not yet possible to determine whether we are witnessing the beginning of a sustained trend that will allow Russians to join the citizens of other developed countries as they progress toward having longer and healthier lives (Christensen et al. 2009 ). Further monitoring of mortality trends in Russia and detailed comparisons with earlier developments in other countries remain a priority for future research if we are to understand the ongoing changes in Russia.
The measures to improve health through primary and secondary prevention of disease that have already been taken should be continued and reinforced. The profile of excess mortality in Russia relative to Western Europe suggests that the priorities in Russia should be discouraging alcohol consumption and tobacco use, and the provision of more effective and universally available health care. 1970 1975 1980 1985 1990 1995 2000 2005 2010 1970 1975 1980 1985 1990 1995 2000 2005 2010 Note: $ A15-A19,B90,A00-A14,A20-B89,B91-B99,F10,J40-J47,P00-P96,Q00-Q99.
